References
- VillasboasJCAnsellSCheckpoint inhibition: programmed cell death 1 and programmed cell death 1 ligand inhibitors in Hodgkin lymphomaCancer J2016221172226841012
- FrimerMLevanoKSRodriguez-GabinAGermline mutations of the DNA repair pathways in uterine serous carcinomaGynecol Oncol2016141110110727016235
- WeberTKChinHMRodriguez-BigasMNovel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancerJAMA1999281242316232010386556
- LeDTUramJNWangHPD-1 blockade in tumors with mismatch-repair deficiencyN Engl J Med2015372262509252026028255
- LinAYLinEProgrammed death 1 blockade, an Achilles heel for MMR-deficient tumors?J Hematol Oncol2015812426542241
- LeDTUranJNWangHPD-1 blockade in tumors with mismatch-repair deficiencyN Engl J Med201537525092520
- LeeVLeDTEfficacy of PD-1 blockade in tumors with MMR defi-ciencyImmunotherapy2016811326643016
- LeeSJYangAWuTCHungC-FImmunotherapy for human papillo-mavirus-associated disease and cervical cancer: review of clinical and translational researchJ Gynecol Oncol2016275e5127329199
- DijkstraKKVoabilPSchumacherTNVoestEEGenomics- and tran-scriptomics-based patient selection for cancer treatment with immune checkpoint inhibitors: a reviewJAMA Oncol20162111490149527491050
- KimJEHongYSRyuMHAssociation between deficient mismatch repair system and efficacy to irinotecan-containing chemotherapy in metastatic colon cancerCancer Sci201110291706171121679278
- KwasniewskaAPostawskiKGozdzicka-JózefiakAZdunekMKorobowiczEMiturskiRImmunohistochemical detection of hMLH1 and hMSH2 proteins in vulvar carcinomaInt J Mol Med200515695596115870899
- CastrilliGFabianoALa TorreGExpression of hMSH2 and hMLH1 proteins of the human DNA mismatch repair system in salivary gland tumorsJ Oral Pathol Med200231423423812076327
- NijhuisERNijmanHWOienKALoss of MSH2 protein expression is a risk factor in early stage cervical cancerJ Clin Pathol200760782483017596548
- CiavattiniAPiccioniMTranquilliALFilosaAPieramiciTGoteriGImmunohistochemical expression of DNA mismatch repair (MMR) system proteins (hMLH1, hMSH2) in cervical preinvasive and invasive lesionsPathol Res Pract20052011212515807307
- ErcoliAFerrandinaGGenuardiMMicrosatellite instability is not related to response to cisplatin-based chemotherapy in cervical cancerInt J Gynecol Cancer200515230831115823117
- BaayMFNakoniecznyMWozniakIMicrosatellite instability and HPV genotype in Polish women with cervical cancerEur J Gynaecol Oncol200930216216619480245
- KöbelMTessier-CloutierBLeoJFrequent mismatch repair protein deficiency in mixed endometrioid and clear cell carcinoma of the endometriumInt J Gynecol Pathol201736655556128114191
- RubioIIbáñez-FeijooEAndrésLAnalysis of Lynch syndrome mismatch repair genes in women with endometrial cancerOncology201691317117627398995
- WangJBMaDLLiJYSunQDLiuYEAssociation between expression of DNA mismatch repair genes and clinical features and prognosis of patients with radical resection of colon cancerGenet Mol Res2016153
- LiGLuCGaoJAssociation between PD-1/PD-L1 and T regulate cells in early recurrent miscarriageInt J Clin Exp Pathol2015866512651826261529
- BrowerVHyperprogressive disease with anti-PD-1 and anti-PD-L1Lancet Oncol201612e527
- ChampiatSDercleLAmmariSHyperprogressive disease is a new pattern of progression in cancer patients treated by anti-PD-1/PD-L1Clin Cancer Res20172381920192827827313
- SloanEARingKLWillisBCModesittSCMillsAMPD-L1 expression in mismatch repair-deficient endometrial carcinomas, including Lynch syndrome-associated and MLH1 promoter hypermethylated tumorsAm J Surg Pathol201741332633327984238
- BoussiotisVAMolecular and biochemical aspects of the PD-1 checkpoint pathwayN Engl J Med2016375181767177827806234
- KataokaKShiraishiYTakedaYAberrant PD-L1 expression through 3′-UTR disruption in multiple cancersNature2016534760740240627281199
- LiYCKorolABFahimaTNevoEMicrosatellites within genes: structure, function, and evolutionMol Biol Evol2004216991100714963101
- GevenslebenHHolmesEEGoltzDPD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomyOncotarget2016748799437995527835597
- GoltzDGevenslebenHDietrichJDietrichDPD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patientsOncoimmunology201661e125745428197377
- KishoreSPiscuoglioSKovacMB3′-UTR poly(T/U) tract deletions and altered expression of EWSR1 are a hallmark of mismatch repair-deficient cancersCancer Res201474122423424158095
- GrinIIshchenkoAAAn interplay of the base excision repair and mismatch repair pathways in active DNA demethylationNucleic Acids Res20164483713372726843430